Diroximel fumarate is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients for relapsing forms of multiple sclerosis. It is a fumarate compound designed to be bioequivalent to dimethyl fumarate but with a modified chemical structure intended to reduce gastrointestinal side effects.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1577222-14-0
IFN-gamma Antagonist
IFN-gamma antagonist peptide
2-(2-Amino-1,3-thiazol-4-yl)-N-(4-(2-((2-phenylethyl)amino)ethyl)phenyl)acetamide
pharmaceutical impurity reference standard
CROMOLYN SODIUM
active pharmaceutical ingredient
Irofulven
active pharmaceutical ingredient
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
YIMYDTCOUQIDMT-SNAWJCMRSA-N
COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O